disoxaril has been researched along with r 61837 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egorova, A; Ekins, S; Makarov, V; Schmidtke, M | 1 |
al-Nakib, W; Andries, K; Dearden, C; Tyrrell, DA; Woestenborghs, R | 1 |
Andries, K; Dewindt, B; van Eemeren, K | 1 |
1 review(s) available for disoxaril and r 61837
Article | Year |
---|---|
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
Topics: Antiviral Agents; Binding Sites; Capsid; Dose-Response Relationship, Drug; Enterovirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2019 |
2 other study(ies) available for disoxaril and r 61837
Article | Year |
---|---|
Drug resistant rhinoviruses from the nose of experimentally treated volunteers.
Topics: Antiviral Agents; Chalcone; Drug Resistance, Microbial; Flavonoids; Humans; Isoxazoles; Microbial Sensitivity Tests; Nose; Pyridazines; Rhinovirus | 1989 |
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
Topics: Adsorption; Antiviral Agents; Capsid; Chalcone; Chalcones; Flavonoids; HeLa Cells; Humans; Isoxazoles; Mutation; Protein Conformation; Pyridazines; Receptors, Virus; Rhinovirus | 1994 |